BIO-TECHNE Corp
General ticker "TECH" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $11.9B
BIO-TECHNE Corp follows the US Stock Market performance with the rate: 29.8%.
Estimated limits based on current volatility of 2.4%: low 70.57$, high 73.97$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-11-11, amount 0.08$ (Y0.44%)
- China accounted for 10.0% of revenue in the fiscal year ended 2023-06-30
- US accounted for 56.5% of revenue in the fiscal year ended 2023-06-30
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-06-30 to 2026-06-30
- 2024-06-30 to 2025-06-30 estimated range: [71.40$, 101.13$]
- 2025-06-30 to 2026-06-30 estimated range: [75.41$, 106.75$]
Financial Metrics affecting the TECH estimates:
- Positive: 0.93 < Non-GAAP EPS, $ of 1.78
- Positive: -3.48 < Investing cash flow per share, $ of -1.29
- Positive: Interest expense per share, $ of 0.10 <= 0.14
- Positive: 9.05 < Operating profit margin, % of 17.83
- Negative: Industry operating cash flow per share per price (median), % of 2.47 <= 3.85
- Positive: Inventory ratio change, % of 0.02 <= 1.08
Short-term TECH quotes
Long-term TECH plot with estimates
Financial data
| YTD | 2022-06-30 | 2023-06-30 | 2024-06-30 |
|---|---|---|---|
| Operating Revenue | $1,105.60MM | $1,136.70MM | $1,159.06MM |
| Operating Expenses | $809.01MM | $837.76MM | $952.37MM |
| Operating Income | $296.59MM | $298.94MM | $206.69MM |
| Non-Operating Income | $4.80MM | $39.72MM | $-21.00MM |
| Interest Expense | $11.31MM | $11.21MM | $15.74MM |
| R&D Expense | $87.14MM | $92.49MM | $96.66MM |
| Income(Loss) | $301.39MM | $338.66MM | $185.69MM |
| Taxes | $38.29MM | $53.22MM | $17.58MM |
| Profit(Loss) | $263.10MM | $285.44MM | $168.10MM |
| Stockholders Equity | $1,701.01MM | $1,966.52MM | $2,068.85MM |
| Inventory | $141.12MM | $171.64MM | $179.73MM |
| Assets | $2,294.80MM | $2,638.69MM | $2,703.87MM |
| Operating Cash Flow | $325.27MM | $254.39MM | $298.98MM |
| Capital expenditure | $44.91MM | $38.24MM | $62.88MM |
| Investing Cash Flow | $-96.85MM | $-265.65MM | $-203.03MM |
| Financing Cash Flow | $-242.85MM | $22.62MM | $-122.40MM |
| Earnings Per Share* | $1.73 | $1.81 | $1.07 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.